Patricia Novo

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study”.

Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

Addiction Science & Clinical Practice(2021)10.1186/s13722-021-00224-y

N/A

0.447DataRank · unranked

9 citations

John Rotrosen, Phoebe Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch +12 more

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and Alcohol Dependence Reports(2022)10.1016/j.dadr.2022.100100

N/A

0DataRank · unranked

2 citations

Tse‐Hwei Choo, Dikla Shmueli‐Blumberg, Martina Pavlicová, Jacquie King, Marc Fishman +9 more

Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder

Addiction(2024)10.1111/add.16473

N/A

0DataRank · unranked

11 citations

Sara Lodi, Heather Hsu, Benjamin J. Bovell-Ammon, Shapei Yan, Dana Bernson +7 more

Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone on Treatment Interruption: Comparing Findings from a Reanalysis of the X:Bot Rct and Harmonized Target Trial Emulation Using Population-Based Observational Data

SSRN Electronic Journal(2024)10.2139/ssrn.4933445

N/A

0DataRank · unranked

0 citations

Shapei Yan, Benjamin J. Bovell-Ammon, Paul J. Christine, Heather Hsu, Dana Bernson +7 more

A clinical trial loses access to some of its experimental treatment conditions: What can be done?

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209854

N/A

0DataRank · unranked

0 citations

Matisyahu Shulman, R D Weiss, Patricia Novo, Scott E. Provost, Michael Otterstatter +4 more